<scp>TIGIT</scp>/<scp>CD47</scp> dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma

Yue Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Huayu He(Peking University), Jiachen Xu(Wenzhou Medical University), Zhenlin Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Qiu(Shandong Academy of Agricultural Sciences), Fenglong Bie(Chinese Academy of Medical Sciences & Peking Union Medical College), Fengwei Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuan Li(Chinese Academy of Medical Sciences & Peking Union Medical College), He Tian(Chinese Academy of Medical Sciences & Peking Union Medical College), Bolun Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Guangyu Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Qilin Huai(Chinese Academy of Medical Sciences & Peking Union Medical College)
Thoracic Cancer
May 24, 2022
10.1111/1759-7714.14478
Cited by 12

Related Papers

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2024|233
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
|Cell|2025|103
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy
|Cancer Science|2023|90
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
|Frontiers in Immunology|2021|84